The RNA m6A reader YTHDF2 depletion phenocopies high glucose induced-cellular stress response in diabetic kidney disease
Harsha Sankar SH, Akhilesh Puranik, Kaustuv Tripathy, Nivedita Singh, Anuradha KesharwaniiD, Vipan Kumar ParihariD, Ruthrothaselvi BharathavikruiD
Abstract
RNA modification, especially the m6A RNA methylation, has been increasingly associated with several physiological and pathophysiological processes. The proteins that help in establishment of the modification and its removal along with the reader proteins that facilitate the functional outcome, together play an important regulatory role in disease manifestation. Diabetic kidney disease (DKD) is one such example, which is categorized as a multifactorial disorder that involves complex metabolic, oxidative, inflammatory, and fibrotic alterations, mediated through genetic, epigenetic and signalling cascades. However, the contribution of m6A-associated RNA regulators in DKD manifestation is relatively less explored. In this study, using HFD+STZ-induced diabetic mice and high glucose-treated renal cell models, we identified the m6A reader protein, Ythdf2 as a consistently downregulated candidate. YTHDF2 depletion in the renal cell line altered cellular viability, proliferation and increased oxidative stress under high-glucose conditions. Click-IT EU labeling further revealed altered RNA processing effects following YTHDF2 depletion and glucose stress. In corroboration with the above observations in animal and cell line models, independent human DKD transcriptomic datasets demonstrated conserved inflammatory and fibrotic signatures as well as reduced YTHDF2 expression in DKD glomeruli. The YTHDF2 downregulation was found to be inversely correlated with several disease-associated inflammatory and fibrotic genes. Together, these findings identify YTHDF2 dysregulation as a potential post-transcriptional mechanism associated with cellular stress and disease-associated molecular programs in DKD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A MEF2C transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease
Ricardo Melo Ferreira, Debora L. Gisch, … Tashas Cameron-Wheeler·Kidney InternationalPeer-reviewed·Apr 27, 2026
- Single-cell transcriptomics reveals a mechanosensitive injury signaling pathway in early diabetic nephropathy
Shuya Liu, Yu Zhao, … Tobias Bruno Huber·Genome MedicinePeer-reviewed·Jan 10, 2023
- ADAM17 Deletion Protects Against Type1 Diabetes-Associated Kidney Injury by Modulating Inflammatory and Fibrotic Pathways
Marta Riera, Claudia Martyn, … Clara Barrios·bioRxiv·Feb 8, 2026
- Hyperactivation of YAP/TAZ drives alterations in mesangial cells through stabilization of N-MYC in diabetic nephropathy
- Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy
S. P. Srivastava, H. Zhou, … J. Goodwin·bioRxiv·Jun 29, 2020
- Alterations in protein translation and carboxylic acid catabolic processes in diabetic kidney disease
Kimberly S. Collins, Michael T. Eadon, … Pierre C. Dagher·CellsPeer-reviewed·Mar 30, 2022